Kinney Horn is CHIEF BUSINESS OFFICER at Olema Pharmaceuticals, Inc. (OLMA). They have made 8 open-market trades across 1 company since 2021, most recently 2026-08-04.
CIK 0001831215
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMNM | SELL · 10b5-1 | 2026-08-04 | 2026-08-06 | $25.09 | $2.3M | +5.5% | +2.5% | — |
| IMNM | SELL · 10b5-1 | 2026-07-07 | 2026-07-09 | $25.00 | $27K | -4.9% | +7.1% | -20.4% |
| OLMA | SELL · 10b5-1 | 2022-03-10 | 2022-03-14 | $4.75 | $25K | +19.3% | -18.3% | -8.0% |
| OLMA | SELL · 10b5-1 | 2022-01-10 | 2022-01-11 | $6.85 | $36K | -12.8% | -28.2% | -54.0% |
| OLMA | SELL | 2021-12-10 | 2021-12-14 | $10.39 | $109K | +7.8% | -26.5% | -55.4% |
| OLMA | SELL | 2021-11-10 | 2021-11-12 | $26.88 | $1.5M | -19.1% | -62.4% | -81.0% |
| OLMA | SELL | 2021-10-11 | 2021-10-12 | $27.90 | $293K | -3.3% | -5.7% | -75.1% |
| OLMA | SELL | 2021-09-10 | 2021-09-13 | $29.38 | $309K | +4.9% | +6.3% | -63.3% |
| OLMA | SELL | 2021-08-10 | 2021-08-11 | $25.70 | $268K | +8.9% | +8.1% | -1.1% |
| OLMA | SELL | 2021-07-12 | 2021-07-13 | $26.43 | $241K | -0.2% | +5.6% | +10.6% |
| OLMA | SELL | 2021-06-10 | 2021-06-11 | $29.76 | $304K | -9.0% | -7.8% | -0.1% |
| OLMA | SELL | 2021-05-18 | 2021-05-19 | $24.15 | $2.8M | +14.0% | +1.1% | +11.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.